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ters, SVD severity was a significant predictor even after cor-
rection for age or CCI.  Conclusions: SVD is a predictor of 
poor outcome and recovery in striatocapsular stroke, inde-
pendent of age or comorbidity. Severe SVD disturbs the in-
tegrity of the cerebral network leading to aggravation of and 
poor recovery from neurological deficits. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 With the advent of modern brain mapping techniques, 
neuroscience theories have shifted from functional local-
ization in specific areas to functional integration, propos-
ing a network of brain regions connected by anatomical 
tracts or functional association. Recovery from stroke is, 
presumably, a function of this widespread network and 
its ability to compensate for the damaged structures and 
to adapt to a given situation  [1, 2] . This ability to recover 
is apparently very different among individuals, as pa-
tients are known to recover from a stroke of similar loca-
tion and size to very varying degrees  [3] . Small vessel dis-
ease (SVD) with lesions in the white matter of the brain 
is a common finding in patients as well as healthy elderly 
individuals and has been implicated to play a prominent 
role in the disruption of the integrity of the cerebral net-
work  [4] . Based on these theories, SVD has been found to 
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 Abstract 
 Background: Recovery from stroke is presumed to be a 
function of a cerebral network. Chronic small vessel disease 
(SVD) has been shown to disrupt this network’s integrity and 
has been proposed as a predictor of poor outcome after 
stroke. We studied this hypothesis in patients with acute 
ischemic stroke of the striatocapsular region, an area of pro-
nounced cortical and subcortical connectivity.  Methods: We 
identified 62 patients with isolated striatocapsular stroke 
from our stroke registry. The standardized workup included 
clinical rating according to the modified Rankin Scale (mRS) 
and MRI, rated according to the Fazekas scale for the extent 
of SVD, ranging from grade 0 to III. MRS at admission, at dis-
charge, and a short-term recovery parameter (the difference 
between mRS at admission and discharge) were correlated 
with the extent of SVD. Comorbidity was assessed with the 
Charlson comorbidity index (CCI).  Results: SVD was graded 
0 in 7%, I in 60%, II in 18%, and III in 16% of patients. The me-
dian mRS at discharge for the groups was 2, 1, 2 and 4, and 
the median recovery parameter was 2, 1, 1 and 0.5, respec-
tively. The extent of SVD significantly correlated with both 
the mRS at discharge and the recovery parameter. While age 
was also a significant predictor of these outcome parame-
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be a predictor of a negative outcome in stroke rather than 
stroke volume and topography, using isolated cerebellar 
infarction as a model  [5] . 
 To further test the hypothesis that the extent of SVD 
has an effect on functional recovery in acute stroke, the 
striatocapsular region seems to be appropriate for a cou-
ple of reasons. Firstly, the striatum is an integral part of 
several frontal-subcortical circuits as described by Alex-
ander and Crutcher [6] and Alexander et al. [7, 8] and as 
such an area of particularly high connectivity involved in 
most of the higher cerebral functions. Secondly, deficits 
from striatocapsular stroke have been well described and 
commonly include a sensorimotor hemisyndrome but 
may also include a disturbance of speech and language or 
neuropsychological deficits  [9] . In this study, we assessed 
the impact of the extent of SVD on the functional out-
come after striatocapsular stroke.
 Materials and Methods 
 Sixty-two patients (22 female, age range 23–91 years) with 
MRI-proven acute, isolated striatocapsular stroke were identified 
from a prospectively collected standardized stroke registry (out of 
5,872 treated between November 2002 and February 2009). All 
patients were treated according to a standardized stroke unit pro-
tocol including cardiovascular and clinical monitoring by a neu-
rologist, physiotherapy and speech therapy and standardized 
stroke care. All clinical data and technical investigations were re-
corded and documented according to a standardized acute stroke 
care protocol. The clinical status on admission was rated before 
thrombolysis (if applicable). In those patients requiring further 
inpatient rehabilitation therapy, the clinical outcome was taken 
from reports from the rehabilitation facility. Ethical approval for 
the collection and analysis of individuals’ data was obtained ac-
cording to appropriate national regulations. MRI was performed 
on a 1.5-tesla MR system (MAGNETOM Sonata, Siemens Medi-
cal Systems) on day 1–11 (mean day 1.5) after admission. A stan-
dardized stroke protocol was used in all patients including T 2 -, 
T 1 -weighted, T 2 -weighted fluid-attenuated inversion recovery, 
time-of-flight magnetic resonance angiography, and diffusion-
weighted echo planar images.
 Acute striatocapsular stroke was identified on diffusion-
weighted MRI as a hyperintense complete or partial lesion of the 
striatum (putamen and caudate nucleus, including the globus pal-
lidus) and the internal capsule. Exclusion criteria were additional 
acute ischemic lesions outside the striatocapsular region, chronic 
territorial ischemic lesions as well as preexisting clinical neuro-
logical deficits. SVD in the deep white matter was identified on 
T 2 -weighted fluid-attenuated inversion recovery images and rat-
ed according to the visual scale set by Fazekas, ranging from 0 (no 
SVD) to 3 (confluent SVD)  [10] . Rating was performed by a single 
rater blinded to relevant parameters (see  fig. 1 for examples). 
 For statistical analysis, a short-term recovery parameter was 
defined as the difference between the modified Rankin Scale 
(mRS) at admission and discharge. For patients discharged to a 
rehabilitation facility, their mRS at discharge from this facility 
was used. In all other cases the mRS at discharge from our depart-
ment was used. The Charlson comorbidity index (CCI) was used 
to assess associated health problems  [11] . It covers 30 diagnoses, 
weighted by their impact on 10-year mortality. The items in the 
CCI were assessed to obtain a total comorbidity score to use in 
statistical analysis. Kendall’s   rank correlation was performed to 
evaluate the influence of SVD on stroke outcome. As a rank-based 
method it is suitable for nonparametric data and is robust  [12] . To 
exclude confounding by age or CCI, Kendall’s   partial rank cor-
relation was included in the analysis  [13] . Fisher’s exact test was 
performed to test for equal distribution among the groups. Cal-
culations were performed using the R statistical package (The R 
Foundation for Statistical Computing, version 2.9.2).
 Results 
 The most common symptoms leading to presentation 
were hemiparesis (n = 59, 95%), hemihypesthesia (n = 34, 
56%), dysarthria (n = 37, 60%), and aphasia (n = 21, 34%). 
Median mRS on admission was 4 (3–5). The extent of 
white matter lesions was graded 0 in 4, I in 37, II in 11, 
and III in 10 patients, respectively. Thirty-six of the 62 
patients (58%) were discharged to an inpatient rehabilita-
tion facility, and 26 patients (42%) could be discharged 
home requiring only ambulatory physiotherapy. The 
mean length of inpatient treatment was 9.1 days (range 
3–18) for the first group and 54.7 days (range 15–106) for 
the second group. The median mRS at discharge when 
grouped by Fazekas grade 0–3 was 2 (1.75–2), 1 (1–3), 2 
 Fig. 1. Example of MRI findings in 2 acute striatocapsular stroke 
patients with SVD Fazekas grade I (upper row) and SVD Fazekas 
grade III (bottom row). 
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(2–3) and 4 (2.25–4), respectively, and the median recov-
ery parameter, defined as the difference between mRS on 
admission and discharge, was 2 (0.75–3.25), 1 (1–2), 1 (0–
1) and 0.5 (0–1), respectively.  Table 1 provides an over-
view of patient characteristics by the extent of SVD.
 The median mRS on admission was not significantly 
related to the extent of SVD, CCI or age; however, the ex-
tent of SVD showed a significant correlation with age 
(   = 0.387, p value  ! 0.001) and CCI (  = 0.26, p value = 
0.017). The extent of SVD predicted negative outcome in 
terms of mRS at discharge (  = 0.245, p value = 0.02) and 
the recovery parameter (  = –0.315, p value = 0.004). 
These relations largely persisted after correcting for age 
(  = 0.13 and –0.25, p value = 0.13 and 0.005, respectively), 
the CCI (  = 0.20 and –0.29, p value = 0.03 and  ! 0.001, 
respectively), or mRS at baseline, before the index stroke 
(  = 0.21 and 0.30, p value 0.02 and  ! 0.001, respectively). 
 Figures 2 and  3 illustrate this relationship. While none 
of the patients with Fazekas grade 0 required care for dai-
ly needs, more than two thirds of the patients with Faze-
kas grade III did. Furthermore, 20 out of 41 (49%) pa-
tients with no or little SVD (Fazekas grade 0 or I) im-
proved significantly (difference of mRS  6 2), while only 
4 out of 21 (19%) patients with relevant SVD (Fazekas 
grade II or III) improved significantly, and 3 (14%) even 
showed functional deterioration during treatment ( fig. 3 ). 
 Age was also a predictor of a negative outcome in 
terms of final mRS (  = 0.339, p value  ! 0.001) and less so 
of development during treatment (  = –0.247, p value = 
0.01). Similarly, this relationship was still significant after 
correction for Fazekas score for the final mRS (  = 0.27, 
p value = 0.002) but not for the difference in mRS (  = 
–0.14, p value = 0.10). 
 CCI predicted a negative outcome (  = 0.24, p value = 
0.02) but not a difference in functional status. 
 Patients who went to a rehabilitation center after treat-
ment in the acute hospital had a significantly worse status 
at discharge (median mRS at discharge 3 vs. 1, p value 
 ! 0.001) and a trend towards a smaller success of reha-
bilitation (median difference of mRS 1 vs. 1.5, p value = 
0.08). This might be explained by the finding that patients 
with a good primary outcome were in no need of further 
Table 1. P atient data
Fazekas 0 Fazekas I Fazekas II Fazekas III p value
Number 4 37 11 10
Female 3 (75%) 14 (38%) 4 (36%) 5 (50%) 0.511
Subsequent rehabilitation 1 (75%) 20 (54%) 8 (73%) 7 (70%) 0.341
Thrombolytic therapy 2 (50%) 7 (19%) 0 (0%) 1 (10%) 0.111
Mean age 8 SD, years 61.5826.7 69.3810.4 78.785.9 80.885.9 0.00012
CCI 0.5 (0–1.25) 1 (0–2) 2 (1–2.5) 2 (2–3.75) 0.022
Baseline mRS 0 (0–0.25) 1 (0–2) 1 (0–2) 1 (0.25–2) 0.042
mRS at admission 4 (2.75–5) 4 (3–5) 3 (2.5–4) 4 (3.25–4.75) 0.372
mRS at discharge 2 (1.75–2) 1 (1–3) 2 (2–3) 4 (2.25–4) 0.022
Difference of mRS 2 (0.75–3.25) 1 (1–2) 1 (0–1) 0.5 (0–1) 0.0042
Risk factors
Arterial hypertension 2 (50%) 30 (81%) 11 (100%) 10 (100%) 0.041
Diabetes mellitus 0 (0%) 9 (22%) 5 (45%) 5 (50%) 0.151
Smoking 1 (25%) 8 (75%) 0 (0%) 0 (0%) 0.151
HLP 2 (50%) 19 (51%) 3 (27%) 4 (40%) 0.561
Hemiparesis 4 (100%) 36 (97%) 9 (82%) 10 (100%) 0.251
Aphasia 2 (50%) 14 (38%) 3 (27%) 2 (20%) 0.631
Dysarthria 2 (50%) 25 (68%) 4 (36%) 6 (60%) 0.291
Presumed stroke etiology
SVD 1 (25%) 13 (35%) 8 (73%) 5 (50%) 0.131
Cardioembolic 2 (50%) 10 (27%) 1 (9%) 3 (30%) 0.371
Large artery disease 1 (25%) 10 (27%) 1 (9%) 0 (0%) 0.181
Other/unknown 0 (0%) 4 (11%) 1 (9%) 2 (20%) 0.831
F igures in parentheses are ranges or percentages as indicated. HLP = Hyperlipoproteinemia. 
1 Calculated by Fisher’s exact test. 2 Calculated by Kendall’s .
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rehabilitation and patients who had not recovered well 
primarily were unlikely to do so later. SVD was equally 
prevalent in patients who underwent rehabilitation as in 
those who did not (p value = 0.34).
 Other established risk factors, namely diabetes melli-
tus, smoking, hyperlipoproteinemia and male sex, did 
not predict a negative outcome either in terms of func-
tional status on discharge or in terms of development 
during treatment. Arterial hypertension was related to a 
worse outcome in terms of mRS on discharge (p value = 
0.01) but not in terms of course during treatment. While 
there were trends towards more patients with acute isch-
emia of presumed microangiopathic cause in patients 
with more pronounced SVD, and more acute stroke due 
to cardioembolism or large artery disease in patients with 
less pronounced SVD, these trends did not reach statisti-
cal significance. Similarly, patients with less severe SVD 
tended to receive thrombolytic therapy more often than 
patients with severer SVD; however, this trend was not 
statistically significant.
 Discussion 
 In this study, we have shown that in patients with iso-
lated striatocapsular stroke, mRS at discharge and short-
term recovery, as measured by the difference between 
mRS on admission and discharge, depend on the extent 
of SVD. Of the 10 patients who recovered the most (by 3 
or 4 points on the mRS), none had more than mild SVD 
(Fazekas grade 0 or I), while all patients whose status de-
teriorated during treatment (by 1–3 points on the mRS) 
had moderate or severe SVD (Fazekas grade II or III).
 Interestingly, the connection between SVD and the 2 
measures of outcome and age, respectively, is inverse. 
While age is a stronger predictor of poor final status 
than SVD, SVD is a stronger predictor of poor recovery 
during treatment than age. This may be explained by a 
nonsignificant trend toward a better functional status 
on admission in patients with more SVD, or indeed be a 
sign of age being a cause of lower functional status in 
general versus SVD being the cause of poor recovery af-
ter stroke. 
 Recent research has addressed the relationship be-
tween SVD and functional outcome after stroke. In a 
first study on patients with isolated cerebellar infarction, 
functional outcome correlated with the coexistence of 
age-related white matter lesions rather than stroke vol-
ume and topography  [5] . Arsava et al. [14] and Ay et al. 
[15] extended these findings to supratentorial stroke and 
were able to show that this influence is also independent 
of other factors, including age, initial deficit, and infarct 
volume growth. In 2009, Kissela et al. [16] found that se-
vere periventricular white matter disease was signifi-
cantly associated with poor functional outcome at 3 
months. In a recently published study, extensive SVD 
was associated with severe Glasgow Coma Scale scores at 
admission, 30-day mortality, and the relative risk for 
mortality in patients with intracerebral hemorrhage  [17] . 
In an even more detailed approach, Liou et al. [18] evalu-
ated the impact of periventricular SVD and subcortical 















































 Fig. 2. Frequency distribution of the mRS score in patients with 
different degrees of SVD according to the Fazekas score. 
 Fig. 3. Frequency distribution of the short-term outcome param-
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functional outcomes. The authors found an unfavorable 
functional stroke at 30 days in patients with periventric-
ular but not subcortical white matter lesions supporting 
the different roles of different white matter locations. 
However, not all studies have confirmed these findings: 
in 75 first-ever middle cerebral artery strokes, the pres-
ence of white matter lesions on MRI did not predict in-
dependence in activities of daily living 1 year after the 
stroke  [19] . Contradictory results also came from several 
CT-based studies  [20–22] , which could not detect this 
relationship, probably due to the low sensitivity of CT 
scans to detect SVD. 
 Ay et al. [15] demonstrated that SVD increases suscep-
tibility to infarct growth and thus have provided a first 
mechanism explaining how SVD may cause poor recov-
ery from stroke. However, the same group has also dem-
onstrated that this effect is at least partially independent 
of infarct growth  [14] . Based on previous studies indicat-
ing that SVD causes a disruption of the cerebral network, 
we hypothesized that this disruption is the cause of poor 
recovery. Both the cerebellum and the striatum are areas 
of exceptional connectivity and take central positions in 
the circuits that control higher cerebral functions. One 
important difference in our study population compared 
to all others is the fact that we selected patients with sim-
ilar infarct patterns as opposed to analyzing a heteroge-
neous group with ischemic stroke affecting different re-
gions of the brain.
 This study has several limitations. (1) Visual rating 
scales, such as the Fazekas scale, have been argued not to 
be very precise and have low interrater reliability  [23] . (2) 
The interval between admission and discharge is highly 
various between patients and, overall, follow-up is short, 
thus the data only allow a conclusion on short-term func-
tional outcome. (3) The difference in mRS between ad-
mission and discharge provides a way to illustrate a gain 
of abilities and independence during stroke rehabilitation 
which goes beyond functional status at a given point and, 
as it is calculated at an individual level, beyond correcting 
for status at admission. The mRS is, however, an ordinal 
scale and values should not ordinarily be added or sub-
tracted. With this caveat in mind, we still believe that in-
teresting information can be drawn from its use. (4) In 
limiting stroke location to the striatocapsular region we 
have chosen an area of high connectivity and a well-de-
fined, functionally relevant deficit, seemingly ideal to test 
the hypothesis that SVD, via a disturbance of the cerebral 
network, hinders stroke recovery. However, this also lim-
its the extent to which our results can be generalized to 
other stroke locations. Since striatocapsular stroke is a 
rather rare type of ischemia, this also makes for a seem-
ingly limited number of patients in our study. In this re-
spect, this study is in line with other studies, which have 
studied stroke in this location and have reported on sim-
ilar or smaller numbers of patients  [9, 24–26] . We cannot 
exclude that our results have at least been partially influ-
enced by varying degrees of cerebral atrophy in our pa-
tients. On the other hand, the causes of cerebral atrophy 
are manifold and there is some evidence that SVD may at 
least be one of these causes  [27] . So trying to correct for 
atrophy may actually hide some of the veritable effects of 
SVD. Nevertheless, the interactions of age, SVD, cerebral 
atrophy and stroke outcome are interesting and should be 
further investigated in the future.
 While we believe that this and previous studies have 
demonstrated the effect of SVD in recovery from stroke, 
several aspects remain unclear. Knowledge about the in-
teraction of location and mechanism of stroke and the 
locations of SVD is still limited. All studies in this field, 
so far, have used scales of dependence and disability, es-
pecially the Barthel Index and mRS, for assessing the 
clinical relevance. It remains unclear which precise defi-
cits cause the decline of functional status. The question 
still remains whether SVD hinders stroke recovery or 
whether stroke aggravates compensated deficits from 
SVD. More differentiated measures of outcome, such as 
task-specific motor skill tests, may yield important infor-
mation. Modern functional MRI may point a way to fur-
ther investigate network integrity and function in stroke 
and SVD  [28] . 
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